Associate Professor, Pathology, University of Washington School of Medicine

Pathology

Rochelle L. Garcia is an expert in the field of Pathology. She went to University of Washington School of Medicine. Rochelle Garcia is a published doctor. She published 33 publications, including: 'DNA repair mutations and outcomes in ovarian cancer--response.' Doctor Rochelle L. Garcia, MD accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• DNA repair mutations and outcomes in ovarian cancer--response.
• Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
• An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
• HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells.
• Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas.
• Characteristics of women with ovarian carcinoma who have BRCA1 and BRCA2 mutations not identified by clinical testing.
• 53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes.
• Loss of function germline mutations in RAD51D in women with ovarian carcinoma.
• E2F3b over-expression in ovarian carcinomas and in BRCA1 Haploinsufficient fallopian tube epithelium.
• Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinoma.
• BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.
• Biomarkers of progestin therapy resistance and endometrial hyperplasia progression.
• Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
• The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations.
• Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy.
• MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival.
• Loop Electrosurgical Excisional Procedure (LEEP) Done for Discrepancy: Does the Time from HGSIL Affect Pathologic Grade of CIN in LEEP Specimen?
• Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
• Diagnosing endometrial hyperplasia: why is it so difficult to agree?
• Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian ca...
• An evaluation of cervical cancer in women age sixty and over.
• Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?
• Alternate molecular genetic pathways in ovarian carcinomas of common histological types.
• Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
• Epithelioid trophoblastic tumor: review of a rare neoplasm of the chorionic-type intermediate trophoblast.
• Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
• Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations.
• Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up.
• Pathologic findings in prophylactic oophorectomy specimens in high-risk women.
• Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.
• Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas.
• Feasibility of RNA and DNA Extraction from Fresh Pipelle and Archival Endometrial Tissues for Use in Gene Expression and SNP Arrays.

Schools

---

• University Of Washington School Of Medicine

• University Wash Hospital

Doctors Specialties

---

• Cytopathology
• Pathology

Accepted Insurances

---

Education

---

• University of Washington
• University of Washington School of Medicine

Hospital

---

• UW Medicine/Harborview Medical Center

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1073699880
Last Name Of The Provider	GARCIA
First Name Of The Provider	ROCHELLE
View All

Similar Doctors

---

	Dr. Kathi H. Adamson, MD This Doctor is OpenDoctor Recommended.
	Dr. Min Fang, MD This Doctor is OpenDoctor Recommended.
	Dr. Carolyn D. Jordan, MD
	Dr. Bonnie L. Cole, MD This Doctor is OpenDoctor Recommended.
	Dr. Marc Mauney, MD This Doctor is OpenDoctor Recommended.
	Dr. Harry C. Hwang, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian A. Folz, MD This Doctor is OpenDoctor Recommended.
	Dr. Nancy C. Kiviat, MD This Doctor is OpenDoctor Recommended.
	Dr. Ilya Stone, MD This Doctor is OpenDoctor Recommended.
	Dr. Peggy L. Porter, MD
	Dr. Maria R. Stitzel, MD This Doctor is OpenDoctor Recommended.
	Dr. Ronald J. Tickman, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian H. Shirts, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Desiree A. Marshall, MD This Doctor is OpenDoctor Recommended.
	Dr. Jennifer B. Kum, MD This Doctor is OpenDoctor Recommended.
	Dr. Sandra L. White, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles D. Sturgis, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog